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background:  Growth differentiation factor (GDF)-15, a marker of myocardial stress, has demonstrated a clear association with mortality; 
however, the association with myocardial infarction (MI) has been less consistent. We assessed the prognostic performance of GDF-15 for recurrent 
cardiovascular (CV) events in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).
methods: GDF-15 (R&D Systems) was measured at enrollment in 4,035 subjects from MERLIN-TIMI 36, a randomized, placebo controlled trial 
of ranolazine in patients with moderate to high-risk NSTE-ACS. Patients were classified per established cutpoints for GDF-15 of <1,200 (n=2,525), 
1,200-1,800 (n=973) and >1,800 ng/L (n=537). Endpoints of CV death (CVD), MI and heart failure (HF) were adjudicated by a central blinded 
events committee.
results: Patients with higher GDF-15 values tended to be older and more likely to have hypertension, diabetes and prior CV disease. The rates of 
the composite of CVD/MI and CVD/HF, as well as the individual endpoints through 1 year were higher in patients with higher baseline levels of GDF-
15 (p-trend<0.0001 for all endpoints; Fig). This relationship was also apparent as soon as 30 days for CVD/MI (3.6% vs 5.5% vs 8.7%, p<0.0001) 
and CVD/HF (1.2% vs 3.7% vs 10.1%, p<0.0001). Higher GDF-15 levels remained significantly associated with CVD and HF, but not MI, after 
adjustment for multiple factors (Fig).
Conclusions: GDF-15 provided prognostic value for CVD and HF, but not MI, following NSTE-ACS.
